Zhou Zhi-Hua ZH

OmicsDI

Browse
Submit Data
Databases
API

1 Result

Show all Save search Copy query

Show results for

Unknown (1)

Publication Date

Release Date

2017 (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

10

Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trial.

Objective

To compare the efficacy and safety of short-course intravenous levofloxacin (LVFX) 750 mg with a conventional intravenous/oral regimen of LVFX 500 mg in patients from China with complicated urinary tract infections (cUTIs) and acute pyelonephritis (APN).